Farminveste, S.G.P.S., S.A.

4.2

Last Updated 22.10.2025

Issuer Rating

3/7

Performance

Favourable

Risk

High

Recommendation

Sell

Market Cap

€ 97.59M

Buy
Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks

4.2

Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Undervalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Farminveste, S.G.P.S., S.A., through its subsidiaries, engages in the pharmacies, pharmaceutical distribution, information technologies, healthcare, health market intelligence, real estate, and other services businesses. It distributes pharmaceutical products in Portugal; operates 10 hospitals and 9 clinics in Lisbon, Almada, Oeiras, Cascais, Sintra, Mafra, Torres Vedras, Santarém, Coimbra, Viseu, S. João da Madeira, Matosinhos, and Porto;...

Company Valuation

Undervalued
6/7

From both historical and forecast perspectives, the stock is underpriced compared to similar stocks. In particular, the stock is underpriced on P/E, 'cheap' on EV/EBITDA,

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis
X-channel

Buy

Sell

0 more stocks